Myriad Neuroscience Email Format
Mental Health CareOhio, United States51-200 Employees
Myriad Neuroscience, formerly Assurex Health, operates in the mental health care sector with a focus on pharmacogenomics. Its work centers on helping healthcare providers tailor medication choices for individuals by leveraging genetic information to inform treatment for neuropsychiatric and other medical conditions. The company’s GeneSight test is developed in its Mason, Ohio clinical laboratory and rests on licensed, patented technology from collaboration with Mayo Clinic and Cincinnati Children’s Hospital Medical Center, supported by evidence-based medicine and clinical pharmacology. Targeting healthcare providers and their patients, Myriad Neuroscience seeks to improve prescribing accuracy and patient outcomes by integrating pharmacogenomic insights into clinical decision-making. Established in 2006 and based in Mason, Ohio, the firm positions itself within the personalized medicine landscape by applying genetic factors to predict drug response, with ongoing partnerships and research activity reflected in recent industry collaborations.